Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challenges
- PMID: 32482367
- PMCID: PMC7247483
- DOI: 10.1016/j.jmii.2020.05.010
Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challenges
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no competing interests.
References
-
- Wang H., Wang Y., Yang Q.W., Ni Y.X., Lin L.K., Luo Y.P. A national survey on fungal infection diagnostic capacity in the clinical mycology laboratories of tertiary care hospitals in China. J Microbiol Immunol Infect. 2020;20:30076–30081. - PubMed
-
- Kung H.C., Huang P.Y., Chen W.T., Ko B.S., Chen Y.C., Chang S.C. 2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan. J Microbiol Immunol Infect. 2018;51:1–17. - PubMed
-
- Ahmad S., Khan Z. Invasive candidiasis: a review of nonculture-based laboratory diagnostic methods. Indian J Med Microbiol. 2012;30:264–269. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
